207 related articles for article (PubMed ID: 31480509)
1. How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity.
Ramis R; Ortega-Castro J; Caballero C; Casasnovas R; Cerrillo A; Vilanova B; Adrover M; Frau J
Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31480509
[TBL] [Abstract][Full Text] [Related]
2. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.
Ahmad S; Shahab U; Baig MH; Khan MS; Khan MS; Srivastava AK; Saeed M; Moinuddin
PLoS One; 2013; 8(9):e72128. PubMed ID: 24023728
[TBL] [Abstract][Full Text] [Related]
4. Study of pyridoxamine against glycation and reactive oxygen species production in human serum albumin as model protein: An in vitro & ex vivo approach.
Abdullah KM; Qais FA; Ahmad I; Hasan H; Naseem I
Int J Biol Macromol; 2018 Dec; 120(Pt B):1734-1743. PubMed ID: 30268752
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.
Voziyan PA; Hudson BG
Cell Mol Life Sci; 2005 Aug; 62(15):1671-81. PubMed ID: 15905958
[TBL] [Abstract][Full Text] [Related]
6. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine.
Chetyrkin SV; Mathis ME; Ham AJ; Hachey DL; Hudson BG; Voziyan PA
Free Radic Biol Med; 2008 Apr; 44(7):1276-85. PubMed ID: 18374270
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the chemical reactivity of pyridoxamine, Ac-Phe-Lys and Ac-Cys with various glycating carbonyl compounds.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Amino Acids; 2009 Mar; 36(3):437-48. PubMed ID: 18480960
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxamine: the many virtues of a maillard reaction inhibitor.
Voziyan PA; Hudson BG
Ann N Y Acad Sci; 2005 Jun; 1043():807-16. PubMed ID: 16037308
[TBL] [Abstract][Full Text] [Related]
9. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
Booth AA; Khalifah RG; Todd P; Hudson BG
J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical impact of antioxidants on post-Amadori glycoxidation: Counterintuitive increase in the yields of pentosidine and Nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative.
Culbertson SM; Vassilenko EI; Morrison LD; Ingold KU
J Biol Chem; 2003 Oct; 278(40):38384-94. PubMed ID: 12878609
[TBL] [Abstract][Full Text] [Related]
11. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
Voziyan PA; Khalifah RG; Thibaudeau C; Yildiz A; Jacob J; Serianni AS; Hudson BG
J Biol Chem; 2003 Nov; 278(47):46616-24. PubMed ID: 12975371
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
Sourris KC; Watson A; Jandeleit-Dahm K
Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
[TBL] [Abstract][Full Text] [Related]
13. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
Booth AA; Khalifah RG; Hudson BG
Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a novel radical trapping and carbonyl group trapping anti-AGE agent: a pyridoxamine analogue for inhibiting advanced glycation (AGE) and lipoxidation (ALE) end products.
Culbertson SM; Enright GD; Ingold KU
Org Lett; 2003 Jul; 5(15):2659-62. PubMed ID: 12868883
[TBL] [Abstract][Full Text] [Related]
15. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine.
Onorato JM; Jenkins AJ; Thorpe SR; Baynes JW
J Biol Chem; 2000 Jul; 275(28):21177-84. PubMed ID: 10801874
[TBL] [Abstract][Full Text] [Related]
16. Theoretical calculations of stability constants and pKa values of metal complexes in solution: application to pyridoxamine-copper(II) complexes and their biological implications in AGE inhibition.
Casasnovas R; Ortega-Castro J; Donoso J; Frau J; Muñoz F
Phys Chem Chem Phys; 2013 Oct; 15(38):16303-13. PubMed ID: 23999915
[TBL] [Abstract][Full Text] [Related]
17. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
Ahmad MS; Pischetsrieder M; Ahmed N
Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
Pereira-Simon S; Rubio GA; Xia X; Cai W; Choi R; Striker GE; Elliot SJ
PLoS One; 2016; 11(7):e0159666. PubMed ID: 27428057
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats.
Zhu P; Lin H; Sun C; Lin F; Yu H; Zhuo X; Zhou C; Deng Z
Mol Med Rep; 2012 Mar; 5(3):655-62. PubMed ID: 22200727
[TBL] [Abstract][Full Text] [Related]
20. Chelating activity of advanced glycation end-product inhibitors.
Price DL; Rhett PM; Thorpe SR; Baynes JW
J Biol Chem; 2001 Dec; 276(52):48967-72. PubMed ID: 11677237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
